Axsome Therapeutics (AXSM) Net Cash Flow Growth (5y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.49% |
| Dec 31, 2025 | 33.86% |
| Sep 30, 2025 | 13.77% |
| Jun 30, 2025 | 18.31% |
| Mar 31, 2025 | 8.61% |
| Dec 31, 2024 | -15.64% |
| Sep 30, 2024 | 25.84% |
| Jun 30, 2024 | -27.86% |
| Mar 31, 2024 | -31.36% |
| Dec 31, 2023 | -89.22% |
| Sep 30, 2023 | -31.98% |
| Jun 30, 2023 | 100.43% |
| Mar 31, 2023 | 52.25% |
| Dec 31, 2022 | -67.95% |
| Sep 30, 2022 | 92.43% |
| Jun 30, 2022 | -10.00% |
| Mar 31, 2022 | -17.19% |
| Dec 31, 2021 | -65.21% |
| Sep 30, 2021 | -40.38% |
| Jun 30, 2021 | -34.50% |
| Mar 31, 2021 | -37.16% |
| Dec 31, 2020 | -19.39% |
| Sep 30, 2020 | 53.46% |
| Jun 30, 2020 | -27.76% |
| Mar 31, 2020 | -89.48% |